ArticleCancer science2017

Gankyrin induces STAT3 activation in tumor microenvironment and sorafenib resistance in hepatocellular carcinoma.

Toshiharu Sakurai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.